BABA vs HERE

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

Despite a strong Piotroski F-Score of 7/9 and a current price ($3.10) trading significantly below both the Graham Number ($5.86) and Intrinsic Value ($4.62), the company is exhibiting signs of a fundamental business collapse. A catastrophic YoY revenue decline of 75.60% and a negative operating margin of -21.56% suggest that the core business model is failing, while the high net profit margin indicates non-operating gains rather than operational success. The technical trend is aggressively bearish, with a 56.3% drop in the last six months, overriding the apparent balance sheet health.